Cargando…

TRPM2 Channel in Microglia as a New Player in Neuroinflammation Associated With a Spectrum of Central Nervous System Pathologies

Microglial cells in the central nervous system (CNS) are crucial in maintaining a healthy environment for neurons to function properly. However, aberrant microglial cell activation can lead to excessive generation of neurotoxic proinflammatory mediators and neuroinflammation, which represents a cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Malko, Philippa, Syed Mortadza, Sharifah A., McWilliam, Joseph, Jiang, Lin-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423084/
https://www.ncbi.nlm.nih.gov/pubmed/30914955
http://dx.doi.org/10.3389/fphar.2019.00239
_version_ 1783404478348656640
author Malko, Philippa
Syed Mortadza, Sharifah A.
McWilliam, Joseph
Jiang, Lin-Hua
author_facet Malko, Philippa
Syed Mortadza, Sharifah A.
McWilliam, Joseph
Jiang, Lin-Hua
author_sort Malko, Philippa
collection PubMed
description Microglial cells in the central nervous system (CNS) are crucial in maintaining a healthy environment for neurons to function properly. However, aberrant microglial cell activation can lead to excessive generation of neurotoxic proinflammatory mediators and neuroinflammation, which represents a contributing factor in a wide spectrum of CNS pathologies, including ischemic stroke, traumatic brain damage, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, psychiatric disorders, autism spectrum disorders, and chronic neuropathic pain. Oxidative stress is a salient and common feature of these conditions and has been strongly implicated in microglial cell activation and neuroinflammation. The transient receptor potential melastatin-related 2 (TRPM2) channel, an oxidative stress-sensitive calcium-permeable cationic channel, is highly expressed in microglial cells. In this review, we examine the recent studies that provide evidence to support an important role for the TRPM2 channel, particularly TRPM2-mediated Ca(2+) signaling, in mediating microglial cell activation, generation of proinflammatory mediators and neuroinflammation, which are of relevance to CNS pathologies. These findings lead to a growing interest in the TRPM2 channel, a new player in neuroinflammation, as a novel therapeutic target for CNS diseases.
format Online
Article
Text
id pubmed-6423084
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-64230842019-03-26 TRPM2 Channel in Microglia as a New Player in Neuroinflammation Associated With a Spectrum of Central Nervous System Pathologies Malko, Philippa Syed Mortadza, Sharifah A. McWilliam, Joseph Jiang, Lin-Hua Front Pharmacol Pharmacology Microglial cells in the central nervous system (CNS) are crucial in maintaining a healthy environment for neurons to function properly. However, aberrant microglial cell activation can lead to excessive generation of neurotoxic proinflammatory mediators and neuroinflammation, which represents a contributing factor in a wide spectrum of CNS pathologies, including ischemic stroke, traumatic brain damage, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, psychiatric disorders, autism spectrum disorders, and chronic neuropathic pain. Oxidative stress is a salient and common feature of these conditions and has been strongly implicated in microglial cell activation and neuroinflammation. The transient receptor potential melastatin-related 2 (TRPM2) channel, an oxidative stress-sensitive calcium-permeable cationic channel, is highly expressed in microglial cells. In this review, we examine the recent studies that provide evidence to support an important role for the TRPM2 channel, particularly TRPM2-mediated Ca(2+) signaling, in mediating microglial cell activation, generation of proinflammatory mediators and neuroinflammation, which are of relevance to CNS pathologies. These findings lead to a growing interest in the TRPM2 channel, a new player in neuroinflammation, as a novel therapeutic target for CNS diseases. Frontiers Media S.A. 2019-03-12 /pmc/articles/PMC6423084/ /pubmed/30914955 http://dx.doi.org/10.3389/fphar.2019.00239 Text en Copyright © 2019 Malko, Syed Mortadza, McWilliam and Jiang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Malko, Philippa
Syed Mortadza, Sharifah A.
McWilliam, Joseph
Jiang, Lin-Hua
TRPM2 Channel in Microglia as a New Player in Neuroinflammation Associated With a Spectrum of Central Nervous System Pathologies
title TRPM2 Channel in Microglia as a New Player in Neuroinflammation Associated With a Spectrum of Central Nervous System Pathologies
title_full TRPM2 Channel in Microglia as a New Player in Neuroinflammation Associated With a Spectrum of Central Nervous System Pathologies
title_fullStr TRPM2 Channel in Microglia as a New Player in Neuroinflammation Associated With a Spectrum of Central Nervous System Pathologies
title_full_unstemmed TRPM2 Channel in Microglia as a New Player in Neuroinflammation Associated With a Spectrum of Central Nervous System Pathologies
title_short TRPM2 Channel in Microglia as a New Player in Neuroinflammation Associated With a Spectrum of Central Nervous System Pathologies
title_sort trpm2 channel in microglia as a new player in neuroinflammation associated with a spectrum of central nervous system pathologies
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423084/
https://www.ncbi.nlm.nih.gov/pubmed/30914955
http://dx.doi.org/10.3389/fphar.2019.00239
work_keys_str_mv AT malkophilippa trpm2channelinmicrogliaasanewplayerinneuroinflammationassociatedwithaspectrumofcentralnervoussystempathologies
AT syedmortadzasharifaha trpm2channelinmicrogliaasanewplayerinneuroinflammationassociatedwithaspectrumofcentralnervoussystempathologies
AT mcwilliamjoseph trpm2channelinmicrogliaasanewplayerinneuroinflammationassociatedwithaspectrumofcentralnervoussystempathologies
AT jianglinhua trpm2channelinmicrogliaasanewplayerinneuroinflammationassociatedwithaspectrumofcentralnervoussystempathologies